Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna M Jansen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Chemical Biology|August 4, 2004
Target-biased scoring approaches and expert systems in structure-based virtual screeningJohanna M Jansen, Eric J Martin
Journal of Chemical Information and Modeling|February 7, 2020
Biased Diversity for Effective Virtual ScreeningEric J Martin, Johanna M Jansen
Journal of Molecular Graphics & Modelling|October 23, 2012
Teach-Discover-Treat (TDT): collaborative computational drug discovery for neglected diseasesJohanna M Jansen, Wendy Cornell, Y Jane Tseng, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitorsSavithri Ramurthy, Abran Costales, Johanna M Jansen, et al.
Cell Chemical Biology|August 21, 2018
Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding SiteZhenhao Fang, Christopher B Marshall, Tadateru Nishikawa, et al.
Journal of Chemical Information and Modeling|April 4, 2019
Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding CampaignsJohanna M Jansen, Gianfranco De Pascale, Susan Fong, et al.
F1000Research|September 21, 2017
Virtual-screening workflow tutorials and prospective results from the Teach-Discover-Treat competition 2014 against malariaSereina Riniker, Gregory A Landrum, Floriane Montanari, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitorsChristopher M McBride, Paul A Renhowe, Thomas G Gesner, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinasesChristopher M McBride, Paul A Renhowe, Carla Heise, et al.
ACS Infectious Diseases|September 4, 2019
Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight LimitsFiorella Ruggiu, Shengtian Yang, Robert L Simmons, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Chemical Biology|August 4, 2004
Target-biased scoring approaches and expert systems in structure-based virtual screeningJohanna M Jansen, Eric J Martin
Journal of Chemical Information and Modeling|February 7, 2020
Biased Diversity for Effective Virtual ScreeningEric J Martin, Johanna M Jansen
Journal of Molecular Graphics & Modelling|October 23, 2012
Teach-Discover-Treat (TDT): collaborative computational drug discovery for neglected diseasesJohanna M Jansen, Wendy Cornell, Y Jane Tseng, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitorsSavithri Ramurthy, Abran Costales, Johanna M Jansen, et al.
Cell Chemical Biology|August 21, 2018
Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding SiteZhenhao Fang, Christopher B Marshall, Tadateru Nishikawa, et al.
Journal of Chemical Information and Modeling|April 4, 2019
Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding CampaignsJohanna M Jansen, Gianfranco De Pascale, Susan Fong, et al.
F1000Research|September 21, 2017
Virtual-screening workflow tutorials and prospective results from the Teach-Discover-Treat competition 2014 against malariaSereina Riniker, Gregory A Landrum, Floriane Montanari, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitorsChristopher M McBride, Paul A Renhowe, Thomas G Gesner, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinasesChristopher M McBride, Paul A Renhowe, Carla Heise, et al.
ACS Infectious Diseases|September 4, 2019
Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight LimitsFiorella Ruggiu, Shengtian Yang, Robert L Simmons, et al.
Pageof 3